Pfizer Inc PFIZER Bond
PFE Stock | USD 26.27 0.05 0.19% |
Pfizer Inc holds a debt-to-equity ratio of 0.398. At present, Pfizer's Net Debt is projected to increase significantly based on the last few years of reporting. The current year's Long Term Debt is expected to grow to about 63.5 B, whereas Long Term Debt Total is forecasted to decline to about 39.6 B. Pfizer's financial risk is the risk to Pfizer stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
Pfizer's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Pfizer's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Pfizer Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Pfizer's stakeholders.
For most companies, including Pfizer, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for the executing running Pfizer Inc the most critical issue when dealing with liquidity needs is whether the current assets are properly aligned with its current liabilities. If not, management will need to obtain alternative financing to ensure that there are always enough cash equivalents on the balance sheet in reserve to pay for obligations.
Price Book 1.6451 | Book Value 15.766 | Operating Margin (0.50) | Profit Margin 0.0362 | Return On Assets 0.0155 |
Pfizer |
Given the importance of Pfizer's capital structure, the first step in the capital decision process is for the management of Pfizer to decide how much external capital it will need to raise to operate in a sustainable way. Once the amount of financing is determined, management needs to examine the financial markets to determine the terms in which the company can boost capital. This move is crucial to the process because the market environment may reduce the ability of Pfizer Inc to issue bonds at a reasonable cost.
Popular Name | Pfizer PFIZER INC 72 |
Specialization | Pharmaceuticals, Biotechnology & Life Sciences |
Equity ISIN Code | US7170811035 |
Bond Issue ISIN Code | US717081CY74 |
Pfizer Inc Outstanding Bond Obligations
PFIZER INC 4125 | US717081ED10 | Details | |
PFIZER INC 4 | US717081EC37 | Details | |
PFIZER INC 3 | US717081EA70 | Details | |
PFIZER INC 34 | US717081DM28 | Details | |
PFIZER INC 44 | US717081DK61 | Details | |
PFIZER INC 275 | US717081DV27 | Details | |
US717081DT70 | US717081DT70 | Details | |
PFIZER INC | US717081EZ22 | Details | |
PFE 175 18 AUG 31 | US717081FB45 | Details | |
PFIZER INC | US717081FA61 | Details | |
PFIZER INC 42 | US717081EK52 | Details | |
PFIZER INC 41 | US717081EJ89 | Details | |
PFIZER INC 36 | US717081EP40 | Details | |
PFIZER INC | US717081EU35 | Details | |
PFIZER INC | US717081ET61 | Details | |
PFIZER INC | US717081EY56 | Details | |
PFIZER INC | US717081EX73 | Details | |
PFIZER INC | US717081EW90 | Details | |
PFIZER INC | US717081EV18 | Details | |
PFIZER INC 72 | US717081CY74 | Details | |
PFIZER INC 43 | US717081DE02 | Details |
Understaning Pfizer Use of Financial Leverage
Pfizer financial leverage ratio helps in determining the effect of debt on the overall profitability of the company. It measures Pfizer's total debt position, including all of outstanding debt obligations, and compares it with the equity. In simple terms, the high financial leverage means the cost of production, together with running the business day-to-day, is high, whereas, lower financial leverage implies lower fixed cost investment in the business and generally considered by investors to be a good sign. So if creditors own a majority of Pfizer assets, the company is considered highly leveraged. Understanding the composition and structure of overall Pfizer debt and outstanding corporate bonds gives a good idea of how risky the capital structure of a business and if it is worth investing in it. Financial leverage can amplify the potential profits to Pfizer's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Pfizer's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets).
Last Reported | Projected for Next Year | ||
Short and Long Term Debt Total | 75 B | 78.8 B | |
Net Debt | 72.2 B | 75.8 B | |
Short Term Debt | 10.9 B | 5.7 B | |
Long Term Debt | 60.5 B | 63.5 B | |
Long Term Debt Total | 61.5 B | 39.6 B | |
Short and Long Term Debt | 10.3 B | 7.8 B | |
Net Debt To EBITDA | 6.86 | 7.20 | |
Debt To Equity | 0.81 | 0.85 | |
Interest Debt Per Share | 13.25 | 13.92 | |
Debt To Assets | 0.32 | 0.16 | |
Long Term Debt To Capitalization | 0.41 | 0.43 | |
Total Debt To Capitalization | 0.45 | 0.24 | |
Debt Equity Ratio | 0.81 | 0.85 | |
Debt Ratio | 0.32 | 0.16 | |
Cash Flow To Debt Ratio | 0.12 | 0.11 |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Pfizer Inc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out the analysis of Pfizer Fundamentals Over Time. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for Pfizer Stock analysis
When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.76) | Dividend Share 1.64 | Earnings Share 0.37 | Revenue Per Share 10.366 | Quarterly Revenue Growth (0.41) |
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pfizer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.